Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Bruno

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Antibiotics (Basel, Switzerland)|July 27, 2022
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy?Marta Colaneri, Domenico Di Carlo, Alessandro Amatu, et al.
Infectious Diseases and Therapy|May 17, 2023
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort StudyErika Asperges, Giuseppe Albi, Valentina Zuccaro, et al.
Cellular & Molecular Immunology|October 16, 2020
Unique immunological profile in patients with COVID-19Stefania Varchetta, Dalila Mele, Barbara Oliviero, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 14, 2020
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospitalEmanuele Cereda, Laura Bogliolo, Catherine Klersy, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Can Alveolar-Arterial Difference and Lung Ultrasound Help the Clinical Decision Making in Patients with COVID-19?Gianmarco Secco, Francesco Salinaro, Carlo Bellazzi, et al.
Blood Purification|November 12, 2020
Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 PneumoniaTeresa Rampino, Marilena Gregorini, Luciano Perotti, et al.
American Journal of Hematology|December 4, 2009
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini, Michele Merli, Francesco Passamonti, et al.
Thrombosis and Haemostasis|February 14, 2014
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological responseMaria Elisa Mancuso, Silvia Linari, Alessio Aghemo, et al.
Journal of Personalized Medicine|August 27, 2021
Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)Pietro Valsecchi, Marta Colaneri, Valentina Zuccaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infectionPaolo Sacchi, Serena Cima, Marta Corbella, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Antibiotics (Basel, Switzerland)|July 27, 2022
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy?Marta Colaneri, Domenico Di Carlo, Alessandro Amatu, et al.
Infectious Diseases and Therapy|May 17, 2023
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort StudyErika Asperges, Giuseppe Albi, Valentina Zuccaro, et al.
Cellular & Molecular Immunology|October 16, 2020
Unique immunological profile in patients with COVID-19Stefania Varchetta, Dalila Mele, Barbara Oliviero, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 14, 2020
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospitalEmanuele Cereda, Laura Bogliolo, Catherine Klersy, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Can Alveolar-Arterial Difference and Lung Ultrasound Help the Clinical Decision Making in Patients with COVID-19?Gianmarco Secco, Francesco Salinaro, Carlo Bellazzi, et al.
Blood Purification|November 12, 2020
Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 PneumoniaTeresa Rampino, Marilena Gregorini, Luciano Perotti, et al.
American Journal of Hematology|December 4, 2009
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini, Michele Merli, Francesco Passamonti, et al.
Thrombosis and Haemostasis|February 14, 2014
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological responseMaria Elisa Mancuso, Silvia Linari, Alessio Aghemo, et al.
Journal of Personalized Medicine|August 27, 2021
Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)Pietro Valsecchi, Marta Colaneri, Valentina Zuccaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infectionPaolo Sacchi, Serena Cima, Marta Corbella, et al.
Pageof 27